Shanghai - Delayed Quote CNY

China Life Insurance Company Limited (601628.SS)

38.26
-0.56
(-1.44%)
As of 11:26:29 AM GMT+8. Market Open.
Loading Chart for 601628.SS
  • Previous Close 38.82
  • Open 38.50
  • Bid 38.26 x --
  • Ask 38.26 x --
  • Day's Range 38.25 - 38.66
  • 52 Week Range 28.96 - 50.88
  • Volume 4,522,708
  • Avg. Volume 13,870,909
  • Market Cap (intraday) 903.028B
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) 9.40
  • EPS (TTM) 4.07
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 0.63 (1.62%)
  • Ex-Dividend Date Nov 13, 2024
  • 1y Target Est --

China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates through: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses segments. It offers critical illness protection, annuity, children/women/old-age, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company.

www.e-chinalife.com

98,689

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 601628.SS

View More

Performance Overview: 601628.SS

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

601628.SS
8.73%
SSE Composite Index (000001.SS)
0.33%

1-Year Return

601628.SS
18.18%
SSE Composite Index (000001.SS)
6.62%

3-Year Return

601628.SS
64.88%
SSE Composite Index (000001.SS)
8.59%

5-Year Return

601628.SS
55.05%
SSE Composite Index (000001.SS)
16.02%

Compare To: 601628.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 601628.SS

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    916.26B

  • Enterprise Value

    857.27B

  • Trailing P/E

    9.54

  • Forward P/E

    13.57

  • PEG Ratio (5yr expected)

    0.69

  • Price/Sales (ttm)

    3.73

  • Price/Book (mrq)

    2.06

  • Enterprise Value/Revenue

    2.91

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    37.51%

  • Return on Assets (ttm)

    1.22%

  • Return on Equity (ttm)

    22.64%

  • Revenue (ttm)

    306.86B

  • Net Income Avi to Common (ttm)

    115.09B

  • Diluted EPS (ttm)

    4.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.07T

  • Total Debt/Equity (mrq)

    41.35%

  • Levered Free Cash Flow (ttm)

    13.04B

Research Analysis: 601628.SS

View More

Company Insights: 601628.SS

Research Reports: 601628.SS

View More

People Also Watch